Skip to main content
. 2021 Dec 27;4(1):vdab185. doi: 10.1093/noajnl/vdab185

Figure 2.

Figure 2.

Assessment of progression-free survival (PFS) and overall survival (OS) after GT implant. The Kaplan-Meier analysis for (A) PFS for all GT-treated patients, GT-treated MGMTu patients, and GT-treated MGMTm patients. (B) OS for all GT-treated patients, GT-treated MGMTu patients, and GT-treated MGMTm patients.